Microencapsulated Bifidobacterium longum subsp. infantis ATCC 15697 Favorably Modulates Gut Microbiota and Reduces Circulating Endotoxins in F344 Rats
Figure 2
Effect of alginate-poly-L-lysine-alginate (APA) microencapsulated B. infantis ATCC 15697 supplementation on fecal organic acids concentrations at endpoint (day 38). F344 rats were gavaged daily with APA microencapsulated B. infantis ATCC 15697 or saline during 38 days. Data represent the means ± SEM () of the concentration of organic acids per gram of wet feces at endpoint (day 38). Statistical analysis was performed using unpaired Student’s t-test. Indicates statistical significance between treatment groups ().
